Trials / Completed
CompletedNCT05450874
A Novel MSE Score to Predict rHCC Patients
A Novel MSE Score to Predict the Postoperative Prognosis of Patients With Ruptured Hepatocellular Carcinoma
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 300 (actual)
- Sponsor
- Tongji Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
Develop and validate a novel scoring system based on pathological factors to predict the postoperative survival of patients with rHCC.Patients with rHCC who underwent hepatectomy were recruited from two hospitals.Exploring whether this scoring system is related to prognosis
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | hepatectomy |
Timeline
- Start date
- 2010-02-01
- Primary completion
- 2017-03-01
- Completion
- 2022-06-01
- First posted
- 2022-07-11
- Last updated
- 2022-07-11
Source: ClinicalTrials.gov record NCT05450874. Inclusion in this directory is not an endorsement.